描述
Diagram illustrating the Sirt1 signaling pathway and how nutraceutical compounds may modulate osteoblast and osteoclast activity to support bone mass preservation.
Figure 1
DiagramSource Paper
Targeting Sirt1, AMPK, Nrf2, CK2, and Soluble Guanylate Cyclase with Nutraceuticals: A Practical Strategy for Preserving Bone Mass.Cite This Figure
![Figure 1: Diagram illustrating the Sirt1 signaling pathway and how nutraceutical compounds may modulate osteoblast and osteoclast activity to support bone mass preservation.]() > Source: Mark F McCarty et al. "Targeting Sirt1, AMPK, Nrf2, CK2, and Soluble Guanylate Cyclase with Nutraceutic." *International journal of molecular sciences*, 2022. PMID: [35563167](https://pubmed.ncbi.nlm.nih.gov/35563167/)
<figure> <img src="" alt="Diagram illustrating the Sirt1 signaling pathway and how nutraceutical compounds may modulate osteoblast and osteoclast activity to support bone mass preservation." /> <figcaption>Figure 1. Diagram illustrating the Sirt1 signaling pathway and how nutraceutical compounds may modulate osteoblast and osteoclast activity to support bone mass preservation.<br> Source: Mark F McCarty et al. "Targeting Sirt1, AMPK, Nrf2, CK2, and Soluble Guanylate Cyclase with Nutraceutic." <em>International journal of molecular sciences</em>, 2022. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/35563167/">35563167</a></figcaption> </figure>